Skip to main content
SpringerLink
Log in

An Introduction to Brain Tumor Imaging

  • Chapter
  • First Online:
Tumors of the Central Nervous System, Volume 11

Part of the book series: Tumors of the Central Nervous System ((TCNS,volume 11))

Abstract

Brain tumors are among the leading causes of tumor-related deaths globally; hence considerable research effort is being expended to improve the patient outcome. There are now multiple imaging techniques available for the diagnosis and management of brain tumors in clinical practice, as well as different contrast agents. All these coupled with amino acid tracers newly available in positron emission tomography can offer more accurate tumor diagnosis. The evaluation of tumors using multiple imaging modalities is now one of the trends in neuroradiology, where computed tomography (CT), magnetic resonance imaging (MRI) and molecular imaging all play a vital role in the brain tumor assessment.

In this chapter, we will cover the clinical applications of computed tomography, magnetic resonance imaging with and without gadolinium contrast agents including perfusion weighted imaging, amide proton transfer imaging and magnetic resonance spectroscopy, and positron emission tomography (PET) for the evaluation of brain tumors. The advantages and limitations of each modality, as well as how they perform with respect to certain specific clinical questions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Basu S, Alavi A (2009) Molecular imaging (PET) of brain tumors. Neuroimaging Clin N Am 19(4):625–646

    Article  PubMed  Google Scholar 

  • Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, Kirk GA (2007) Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol 188(2):586–592

    Article  PubMed  Google Scholar 

  • Castillo M, Kwock L, Mukherji SK (1996) Clinical applications of proton MR spectroscopy. AJR Am J Roentgenol 17(1):1–15

    CAS  Google Scholar 

  • Colosimo C, Ruscalleda J, Korves M, La Ferla R, Wool C, Pianezzola P, Kirchin MA (2001) Detection of intracranial metastases: a multicenter, intrapatient comparison of gadobenate dimeglumine-enhanced MRI with routinely used contrast agents at equal dosage. Invest Radiol 36(2):72–81

    Article  PubMed  CAS  Google Scholar 

  • Colosimo C, Knopp MV, Barreau X, Gérardin E, Kirchin MA, Guézénoc F, Lodemann KP (2004) A comparison of Gd-BOPTA and Gd-DOTA for contrast-enhanced MRI of intracranial tumours. Neuroradiology 46(8):655–665

    Article  PubMed  CAS  Google Scholar 

  • Dean BL, Drayer BP, Bird CR, Flom RA, Hodak JA, Coons SW, Carey RG (1990) Gliomas: classification with MR imaging. Radiology 174(2):411–415

    PubMed  CAS  Google Scholar 

  • Donahue MJ, Blakeley JO, Zhou J, Pomper MG, Laterra J, van Zijl PCM (2008) Evaluation of human brain tumor heterogeneity using multiple T1-based MRI signal weighting approaches. Magn Reson Med 59(2):336–344

    Article  PubMed Central  PubMed  Google Scholar 

  • Essig M (2003) Clinical experience with MultiHance in CNS imaging. Eur Radiol 13(Suppl 3):N3–N10

    Article  PubMed  Google Scholar 

  • Essig M, Lodemann K-P, Le-Huu M, Brüning R, Kirchin M, Reith W (2006) Intraindividual comparison of gadobenate dimeglumine and gadobutrol for cerebral magnetic resonance perfusion imaging at 1.5 T. Invest Radiol 41(3):256–263

    Article  PubMed  CAS  Google Scholar 

  • Giesel FL, Mehndiratta A, Risse F, Rius M, Zechmann CM, von Tengg-Kobligk H, Gerigk L, Kauczor HU, Politi M, Essig M, Griffiths PD, Wilkinson ID (2009) Intraindividual comparison between gadopentetate dimeglumine and gadobutrol for magnetic resonance perfusion in normal brain and intracranial tumors at 3 Tesla. Acta Radiol 50(5):521–530

    Article  PubMed  Google Scholar 

  • Giesel FL, Mehndiratta A, Essig M (2010) High-relaxivity contrast-enhanced magnetic resonance neuroimaging: a review. Eur Radiol 20(10):2461–2474

    Article  PubMed  Google Scholar 

  • Howe FA, Opstad KS (2003) 1H MR spectroscopy of brain tumours and masses. NMR Biomed 16(3):123–131

    Article  PubMed  CAS  Google Scholar 

  • Howe FA, Barton SJ, Cudlip SA, Stubbs M, Saunders DE, Murphy M, Wilkins P, Opstad KS, Doyle VL, McLean MA, Bell BA, Griffiths JR (2003) Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 49(2):223–232

    Article  PubMed  CAS  Google Scholar 

  • Kandel EI, Schavinsky YV (1972) Stereotaxic apparatus and operations in Russia in the 19th century. J Neurosurg 37(4):407–411

    Article  PubMed  CAS  Google Scholar 

  • Kuhn MJ, Picozzi P, Maldjian JA, Schmalfuss IM, Maravilla KR, Bowen BC, Wippold FJ, Runge VM, Knopp MV, Wolansky LJ, Gustafsson L, Essig M, Anzalone N (2007) Evaluation of intraaxial enhancing brain tumors on magnetic resonance imaging: intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for visualization and assessment, and implications for surgical intervention. J Neurosurg 106(4):557–566

    Article  PubMed  CAS  Google Scholar 

  • Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW (2002) High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 222(3):715–721

    Article  PubMed  Google Scholar 

  • Maravilla KR, Maldjian JA, Schmalfuss IM, Kuhn MJ, Bowen BC, Wippold FJ, Runge VM, Knopp MV, Kremer S (2006) Contrast enhancement of central nervous system lesions: multicenter intraindividual crossover comparative study of two MR contrast agents. Radiology 240(2):389–400

    Article  PubMed  Google Scholar 

  • Mehndiratta A, Giesel FL (2011) Brain tumor imaging. In: Abujamra AL (ed) Diagnostic techniques and surgical management of brain tumors. InTech, ISBN 978-953-307-589-1

    Google Scholar 

  • Mehndiratta A, Kapal JM, Prabu A (2011) Iodine mapping in brain tumor imaging using dual-energy computed tomography. Med Hypotheses 76(5):764

    Article  PubMed  CAS  Google Scholar 

  • Pauleit D, Zimmermann A, Stoffels G, Bauer D, Risse J, Flüss MO, Hamacher K, Coenen HH, Langen KJ (2006) 18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer. J Nucl Med 47(2):256–261

    PubMed  Google Scholar 

  • Pooley RA (2005) AAPM/RSNA physics tutorial for residents: fundamental physics of MR imaging. Radiographics 25(4):1087–1099

    Article  PubMed  Google Scholar 

  • Rowley HA, Scialfa G, Gao PY, Maldjian JA, Hassell D, Kuhn MJ, Wippold FJ, Gallucci MB, Bowen BC, Schmalfuss IM, Ruscalleda J, Bastianello S, Colosimo C (2008) Contrast-enhanced MR imaging of brain lesions: a large-scale intraindividual crossover comparison of gadobenate dimeglumine versus gadodiamide. AJNR Am J Neuroradiol 29(9):1684–1691

    Article  PubMed  CAS  Google Scholar 

  • Rumboldt Z, Rowley HA, Steinberg F, Maldjian JA, Ruscalleda J, Gustafsson L, Bastianello S (2009) Multicenter, double-blind, randomized, intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine in MRI of brain tumors at 3 tesla. J Magn Reson Imaging 29(4):760–767

    Article  PubMed Central  PubMed  Google Scholar 

  • Shino A, Nakasu S, Matsuda M, Handa J, Morikawa S, Inubushi T (1999) Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy. J Neurosurg 91(6):928–934

    Article  PubMed  CAS  Google Scholar 

  • Sze G, Johnson C, Kawamura Y, Goldberg SN, Lange R, Friedland RJ, Wolf RJ (1998) Comparison of single- and triple-dose contrast material in the MR screening of brain metastases. AJNR Am J Neuroradiol 19(5):821–828

    PubMed  CAS  Google Scholar 

  • Usenius JP, Kauppinen RA, Vainio PA, Hernesniemi JA, Vapalahti MP, Paljärvi LA, Soimakallio S (1994) Quantitative metabolite patterns of human brain tumors: detection by 1H NMR spectroscopy in vivo and in vitro. J Comput Assist Tomogr 18(5):705–713

    Article  PubMed  CAS  Google Scholar 

  • van Zijl PCM, Yadav NN (2011) Chemical exchange saturation transfer (CEST): what is in a name and what isn’t? Magn Reson Med 65(4):927–948

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Wen Z, Hu S, Huang F, Wang X, Guo L, Quan X, Wang S, Zhou J (2010) MR imaging of high-grade brain tumors using endogenous protein and peptide-based contrast. Neuroimage 51(2):616–622

    Article  PubMed Central  PubMed  Google Scholar 

  • Zhou J, Blakeley JO, Hua J, Kim M, Laterra J, Pomper MG, Van Zijl PCM (2008) Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging. Magn Reson Med 60(4):842–849, Prometheus Books

    Article  PubMed Central  PubMed  Google Scholar 

  • Zhou J, Tryggestad E, Wen Z, Lal B, Zhou T, Grossman R, Wang S, Yan K, Fu DX, Ford E, Tyler B, Blakeley J, Laterra J, van Zijl PCM (2011) Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med 17(1):130–134

    Article  PubMed Central  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Keble College, University of Oxford, Parks Road, Oxford, OX1 3PG, UK

    Amit Mehndiratta

  2. Wolfson College, University of Oxford, Linton Road, Oxford, OX2 6UD, UK

    Yee Kai Tee

  3. Institute of Biomedical Engineering, University of Oxford, Old Road Campus Research Building, Headington, Oxford, OX3 7DQ, UK

    Stephen J. Payne & Michael A. Chappell

  4. Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany

    Frederik L. Giesel

Authors
  1. Amit Mehndiratta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yee Kai Tee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stephen J. Payne
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael A. Chappell
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Frederik L. Giesel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amit Mehndiratta .

Editor information

Editors and Affiliations

  1. Kean University, Room 213, Library building, Union, New Jersey, USA

    M.A. Hayat

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Mehndiratta, A., Tee, Y.K., Payne, S.J., Chappell, M.A., Giesel, F.L. (2014). An Introduction to Brain Tumor Imaging. In: Hayat, M. (eds) Tumors of the Central Nervous System, Volume 11. Tumors of the Central Nervous System, vol 11. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-7037-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-94-007-7037-9_1

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-007-7036-2

  • Online ISBN: 978-94-007-7037-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation